[go: up one dir, main page]

DK356984D0 - Gangliosidderivater, praeparater indeholdende disse samt fremgangsmaader til fremstilling deraf - Google Patents

Gangliosidderivater, praeparater indeholdende disse samt fremgangsmaader til fremstilling deraf

Info

Publication number
DK356984D0
DK356984D0 DK356984A DK356984A DK356984D0 DK 356984 D0 DK356984 D0 DK 356984D0 DK 356984 A DK356984 A DK 356984A DK 356984 A DK356984 A DK 356984A DK 356984 D0 DK356984 D0 DK 356984D0
Authority
DK
Denmark
Prior art keywords
ganglioside
sub
procedures
preparing
mono
Prior art date
Application number
DK356984A
Other languages
English (en)
Other versions
DK356984A (da
DK166828B1 (da
Inventor
Ezio Tubaro
Giovanni Cavallo
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK356984D0 publication Critical patent/DK356984D0/da
Publication of DK356984A publication Critical patent/DK356984A/da
Application granted granted Critical
Publication of DK166828B1 publication Critical patent/DK166828B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK356984A 1983-07-21 1984-07-20 Mono-sialo gangliosid gm1p, praeparater indeholdende dette samt anvendelse deraf til fremstilling af et laegemiddel DK166828B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT48724/83A IT1168205B (it) 1983-07-21 1983-07-21 Derivato di monsialo ganglioside dotato di attivita' antibatterica, antifungina ed antitumorale, composizioni che lo contengono e procedimento per la loro preparazione
IT4872483 1983-07-21

Publications (3)

Publication Number Publication Date
DK356984D0 true DK356984D0 (da) 1984-07-20
DK356984A DK356984A (da) 1985-01-22
DK166828B1 DK166828B1 (da) 1993-07-19

Family

ID=11268264

Family Applications (1)

Application Number Title Priority Date Filing Date
DK356984A DK166828B1 (da) 1983-07-21 1984-07-20 Mono-sialo gangliosid gm1p, praeparater indeholdende dette samt anvendelse deraf til fremstilling af et laegemiddel

Country Status (9)

Country Link
US (2) US4728641A (da)
EP (1) EP0136438B1 (da)
JP (1) JPS6084296A (da)
AT (1) ATE75480T1 (da)
DE (1) DE3485680D1 (da)
DK (1) DK166828B1 (da)
ES (1) ES534494A0 (da)
HU (1) HU198091B (da)
IT (1) IT1168205B (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH660557A5 (fr) * 1984-10-26 1987-05-15 Nestle Sa Composition anti-bacterienne et procede de preparation de ses constituants actifs.
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
JPH0653764B2 (ja) * 1985-07-31 1994-07-20 三井東圧化学株式会社 モノシアロガングリオシドの製造法
DE3787403D1 (de) * 1986-05-09 1993-10-21 Pulverer Gerhard Verwendung von spezifischen Monosacchariden zur Herstellung eines Arzneimittels zur Verhinderung von Metastasen maligner Tumore.
IT1208751B (it) * 1986-06-30 1989-07-10 Fidia Farmaceutici Possibile uso dei gangliosidi esogeni in malattie tumorali come fattore protettivo contro la neurotossicita' da farmaci antitumorali
EP0508493A1 (en) * 1986-08-06 1992-10-14 Mect Corporation Ganglioside related compounds and method of producing the same
IT1212041B (it) * 1987-11-02 1989-11-08 Fidia Farmaceutici Gangliosidi esteri interni come agenti terapeutici capaci di eliminare il dolore nelle neuropatie periferiche
AU6902691A (en) * 1989-12-13 1991-07-18 Glycomed Incorporated Synthetic receptor molecules recognizable by a rotavirus
WO1991008748A1 (en) * 1989-12-13 1991-06-27 Glycomed Incorporated Synthesis of rotavirus receptor saccharides
WO1993002686A1 (en) * 1991-07-31 1993-02-18 The Regents Of The University Of California Gangliosides with immunosuppressive ceramide moieties
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
DE4204907A1 (de) * 1992-02-14 1993-08-19 Reutter Werner Neuartige glykokonjugate mit n-substituierten neuraminsaeuren als mittel zur stimulierung des immunsystems
TW261533B (da) * 1992-07-16 1995-11-01 Kirin Brewery
JP3717512B2 (ja) * 1992-10-22 2005-11-16 麒麟麦酒株式会社 新規スフィンゴ糖脂質およびその使用
KR100281265B1 (ko) * 1993-04-15 2001-02-01 마나배 게이사꾸 신규한 스핀고당지질 및 그의 사용
DE19602108A1 (de) * 1996-01-22 1997-07-24 Beiersdorf Ag Gegen Bakterien, Parasiten, Protozoen, Mycota und Viren wirksame Substanzen
US5747476A (en) * 1996-07-17 1998-05-05 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoal myeloencephalitis
DE19643585A1 (de) * 1996-10-22 1998-04-23 Beiersdorf Ag Antiadhäsive Sphingolipide
WO2002018402A2 (en) * 2000-09-01 2002-03-07 Neuronyx, Inc. Novel synthetic gangliosides
WO2002018401A2 (en) * 2000-09-01 2002-03-07 Neuronyx, Inc. Novel synthetic gangliosides
US9969980B2 (en) * 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
EP1358910A1 (de) * 2002-05-02 2003-11-05 B.R.A.H.M.S Aktiengesellschaft Verfahren und Mittel zur Prävention, Hemmung und Therapie von Krebserkrankungen
EP1367395A1 (de) * 2002-05-02 2003-12-03 B.R.A.H.M.S Aktiengesellschaft Diagnose von Neoplasmen mit Hilfe von anti-Gangliosid-Antikörpern
US9969977B2 (en) * 2002-09-20 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
AU2004220087A1 (en) 2003-03-06 2004-09-23 Seneb Biosciences, Inc. Methods and compositions for the enzymatic synthesis of gangliosides
JP4965063B2 (ja) * 2004-05-07 2012-07-04 雪印メグミルク株式会社 口腔内細菌叢改善剤、抗菌剤及び生育促進剤。
AU2005287891C1 (en) 2004-09-23 2009-07-16 Csr Building Products Limited Hybrid ventilator
MX2009013672A (es) * 2007-06-15 2010-03-30 Garnet Biotherapeutics Inc Tratamiento de enfermedades y trastornos utilizando celulas formadoras de colonias de autorenovacion cultivadas y expandidas in vitro.
WO2009123877A1 (en) * 2008-03-21 2009-10-08 Braincells, Inc. A method of treating a nervous system disorder by modulation of neurogenesis with mcc-257
DE102010024041A1 (de) * 2010-05-16 2013-04-04 Alfred Kroll Symtomfreiheit der Atemwege

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT295036B (de) * 1968-11-29 1971-12-27 Leikola Erkki E Verfahren zur Herstellung von neuen Produkten tierischen Ursprungs
US4125492A (en) * 1974-05-31 1978-11-14 Pedro Cuatrecasas Affinity chromatography of vibrio cholerae enterotoxin-ganglioside polysaccharide and the biological effects of ganglioside-containing soluble polymers
FR2478104B1 (fr) * 1980-03-17 1986-08-08 Merieux Inst Nouveaux derives de gangliosides, leur preparation et leur application
WO1981003175A1 (en) * 1980-05-09 1981-11-12 H Leffler Carbohydrate derivatives for inhibiting bacterial adherence
CH658458A5 (fr) * 1981-12-17 1986-11-14 Lucchini Lab Sa Procede pour l'obtention du lacto-n-norhexaosyl ceramide.

Also Published As

Publication number Publication date
EP0136438A3 (en) 1987-05-13
DE3485680D1 (de) 1992-06-04
ES8603191A1 (es) 1985-12-01
JPS6084296A (ja) 1985-05-13
DK356984A (da) 1985-01-22
US4831021A (en) 1989-05-16
IT1168205B (it) 1987-05-20
ATE75480T1 (de) 1992-05-15
EP0136438A2 (en) 1985-04-10
EP0136438B1 (en) 1992-04-29
IT8348724A0 (it) 1983-07-21
ES534494A0 (es) 1985-12-01
IT8348724A1 (it) 1985-01-21
HU198091B (en) 1989-07-28
US4728641A (en) 1988-03-01
HUT35690A (en) 1985-07-29
DK166828B1 (da) 1993-07-19

Similar Documents

Publication Publication Date Title
DK356984A (da) Gangliosidderivater, praeparater indeholdende disse samt fremgangsmaader til fremstilling deraf
AU549885B2 (en) Heparin degradation via ascorbic acid, cupric acetate and hydrogen peroxide
IE36724B1 (en) Imidazole derivatives
SE9401406L (sv) Farmaceutiska produkter för att bota tumörsjukdomar samt förfarande för framställning av desamma
ES2033871T3 (es) Un procedimiento para producir una preparacion de insulina para administracion parenteral.
FI931274A0 (fi) Menetelmä puhdistettujen glykolipidien valmistamiseksi käyttäen membraanierotusmenetelmää
ATE27914T1 (de) Verwendung von n-acetyl(alpha, beta) aspartylglutaminsaeure zur herstellung eines arzneimittels mit anti-allergischer wirkung zur lokalen verabreichung.
AU6076886A (en) Novel pharmaceutical compositions intended to the treatment of neuropathies and insuring the nervous regeneration
GR3000838T3 (en) Process for preparing an aquous pharmaceutical solution of an organic acid as the active ingredient
SE7714647L (sv) Immunglobulin med reducerad komplementbindning, forfarande for dess framstellning samt medel innehallande sadant immunglobulin
ES8605282A1 (es) Un procedimiento para la preparacion de acido fructosa 1,6 difosfato
FI50125C (fi) Menetelmä terapeuttisesti käytettävien /1,1-ditienyyli-1-hydroksi-prop yyli-(3)/-/1-fenyyli-alkyyli/-amiinien ja näiden suolojen valmistamise ksi.
FI802089A7 (fi) Fosfonomuurahaishappohydratsideja, menetelmä niiden valmistamiseksi.
FI881075A0 (fi) Menetelmä optisesti aktiivisten, oikealle kiertävien okso-isoindolinyylijohdannaisten valmistamiseksi
CN110882263A (zh) 礁膜寡二糖与礁膜寡二糖衍生物在抗乳腺癌中的应用
GB924701A (en) New polysaccharide and process for preparing same
Trgovčević et al. Preferential degradation of gamma-irradiated deoxyribonucleic acid by crude extract of Escherichia coli
NO158493C (no) Maskin for kvisting av traer som er anordnet i bunter, saerlig sm traer.
CA1017485A (en) Process for preparation of sorbents suitable for the treatment of solutions containing high molecular substances, especially proteins
Que et al. Uncoupling of Na+-dependent solute transport in renal brush border membranes of maleate-treated rats
Binkley Glucose, a Constituent of Alkaline PHOSPHATASE1
GB1274993A (en) Pplo vaccine preparation
Forscher et al. Studies on Physicochemical Phenomena Related To Dental Caries: I. the Effect of Sugar on the Rate of Diffusion of Hydrogen Ion
GB856413A (en) New lipo-polysaccharides of bacterial origin and process for prearing same
Yosizawa et al. Monosaccharides Constituents of the Walls of Rhodopseudomonas spheroides

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed